According to VynZ Research’s latest report, titled “U.S. Drug of Abuse (DoA) Testing Market – Analysis and Forecast (2025-2030)”, the U.S. Drug of Abuse (DoA) Testing Market size is expected to reach USD 4.6 billion by 2030, exhibiting a CAGR of 9.7% during 2025-2030.

A Drug of Abuse DOA screen provides simple qualitative testing that results in positive or negative form testing. This is a testing which starts with a screen and moves toward confirmation of specific drugs, only if the screen is positive.

Request Free Sample Report: https://www.vynzresearch.com/healthcare/us-drug-of-abuse-testing-market/request-sample

U.S. Drug of Abuse (DoA) Testing Market Trends/Growth :

Increasing awareness against drug abuse and development of advanced drug test equipment, government initiatives, stringent laws and regulations, are the various growth drivers for the U.S. DoA testing industry. For this purpose the government in the country is promoting educational initiatives, implementing overdose education, supporting prescription drug monitoring programs and aggressive law enforcement efforts. Furthermore, the investment for research and development by the government is supporting for pain management and next-generation analgesics which is projected to fuel the market for DoA testing in the U.S.

U.S. Drug of Abuse (DoA) Testing Market 2025-2030 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the U.S. Drug of Abuse (DoA) Testing Market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

·        Siemens AG

·        Danaher Corporation,

·        Merck KGaA,

·        Laboratory Corporation

·        Express Diagnostics Int'l Inc.

·        Quest Diagnostics Inc

·        Waters Corporation

·        Abbott Laboratories

·        Psychemedics Corporation

·        Bio-Rad Laboratories, Inc

·        Thermo Fisher Scientific Inc

·        F. Hoffmann-La Roche AG.

Key Market Segmentation:

The report has segmented the U.S. Drug of Abuse (DoA) Testing Market on the basis of type, by Indication, by Distribution Channel and region.

Breakup By Product

·        Immunoassay Analyzers

·        Chromatography Instruments

·        Breath Analyzers

·        Rapid Test Kits

·        Assay Kits & Reagents

·        Others

 Breakup By Sample Type

·        Urine

·        Saliva

·        Hair

·        Blood

·        Breath

·        Others

Breakup By End User

·        Hospitals

·        Diagnostic laboratories

·        On-the-spot Testing

·        Forensic Laboratories

·        Others

Explore Full Report with TOC & List of Figure: https://www.vynzresearch.com/healthcare/us-drug-of-abuse-testing-market

Key Highlights of the Report:

·        Market Performance (2018-2023)

·        Base Year 2024

·        Market Outlook (2025-2030)

·        Market Trends

·        Market Drivers and Success Factors

·        Impact of COVID-19

·        Value Chain Analysis

·        Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

We at VynZ Research offer research, analytics and consulting services on various business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions of the world to strategize business opportunities. We provide valuable insights on the verticals such as Transportation, Energy, Chemicals, Healthcare, Automotive, Consumer Durables, ICT and other emerging technologies.

Contact US:

VynZ Research

H.O - 9591 Fontainblue Blvd. 617

Miami Florida 33172 U.S.A

Email: support@vynzresearch.com

Phone: +91 9960 288 381

Toll Free:1 888 253 3960